Advertisement

Pathology

ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD

THURSDAY, Dec. 10, 2020 (HealthDay News) — Use of the ex vivo CRISPR-Cas9-based gene-editing platform to edit the erythroid enhancer region of BCL11A in hematopoietic stem and progenitor cells, producing CTX001, results in...

Read More

ASH: Black Race Linked to Poorer Survival in AML

TUESDAY, Dec. 8, 2020 (HealthDay News) — Self-reported patient race is the most important factor associated with poorer survival in patients with acute myeloid leukemia (AML), according to a study presented at the annual...

Read More

For latest news and updates
Email-id is invalid